World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
97
Citations
30344
World Ranking
832
National Ranking
28

Medicine

D-Index
98
Citations
31224
World Ranking
8997
National Ranking
270

Overview

Andrew R. Lloyd is affiliated with the University of New South Wales in Australia. Their research activity is primarily situated in the field of Medicine, with notable contributions across several subfields including Epidemiology, Infectious Diseases, Hepatology, Public Health, Environmental and Occupational Health, and Immunology.

The scientist's research topics focus considerably on viral infections and their medical implications. Main areas of work encompass:

  • Hepatitis C virus research
  • Hepatitis B virus studies
  • HIV, drug use, and sexual risk
  • SARS-CoV-2 and COVID-19 research
  • Liver disease diagnosis and treatment
  • Mosquito-borne diseases and control
  • COVID-19 clinical research studies

Frequent collaborators include Rowena A. Bull, Jason Grebely, Gregory J. Dore, Chaturaka Rodrigo, and Behzad Hajarizadeh.

Publication venues where Andrew R. Lloyd has contributed frequently comprise:

  • International Journal of Drug Policy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Journal of Hepatology
  • Scientific Reports

Selected recent papers include:

  • "Long COVID and Post-infective Fatigue Syndrome: A Review," 2021, published in Open Forum Infectious Diseases
  • "Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial," 2023, published in The Lancet Oncology
  • "Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults," 2023, published in JAMA Network Open
  • "Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study," 2021, published in The Lancet. Gastroenterology & Hepatology
  • "Chronic fatigue syndrome: progress and possibilities," 2020, published in The Medical Journal of Australia

Best Publications

  • Recombinant Human Interferon-inducible Protein 10 Is a Chemoattractant for Human Monocytes and T Lymphocytes and Promotes T Cell Adhesion to Endothelial Cells

    Dennis D. Taub;Andrew R. Lloyd;Kevin Conlon;Ji Ming Wang

  • Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study

    Ian Hickie;Tracey Davenport;Denis Wakefield;Ute Vollmer-Conna

  • Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta

    Dennis D. Taub;Kevin Conlon;Andrew R. Lloyd;Joost J. Oppenheim

  • Estimating progression to cirrhosis in chronic hepatitis C virus infection.

    Anthony J. Freeman;Gregory J. Dore;Matthew G. Law;Max Thorpe

  • Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes.

    Raffaele Badolato;Ji Ming Wang;William J Murphy;Andrew R. Lloyd

  • Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response

    Andrew R Lloyd;Joost J Oppenheim

  • Prevalence of chronic fatigue syndrome in an Australian population.

    A R Lloyd;I Hickie;C R Boughton;O Spencer

  • Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution.

    William C Reeves;Andrew Lloyd;Suzanne D Vernon;Nancy Klimas

  • The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

    Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff

  • Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis

    A Masi;D S Quintana;N Glozier;A R Lloyd

  • Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes

    M Kawamura;D W McVicar;J A Johnston;T B Blake

  • Longitudinal study of outcome of chronic fatigue syndrome

    Andrew Wilson;Ian Hickie;Andrew Lloyd;Dusan Hadzi-Pavlovic

  • The psychiatric status of patients with the chronic fatigue syndrome.

    Ian Hickie;Andrew Lloyd;Denis Wakefield;Gordon Parker

  • The role of cytokines in the pathogenesis of inflammatory eye disease

    Denis Wakefield;Andrew Lloyd

  • Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

    Charles E. Harvey;Jeffrey J. Post;Patricia Palladinetti;Anthony J. Freeman

  • Sequential bottlenecks drive viral evolution in early acute Hepatitis C virus infection

    Rowena A. Bull;Fabio Luciani;Kerensa McElroy;Silvana Gaudieri

  • Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

    Jason Grebely;Maria Prins;Margaret Hellard;Andrea L Cox

  • CCR5 Expression Correlates with Susceptibility of Maturing Monocytes to Human Immunodeficiency Virus Type 1 Infection

    Hassan M. Naif;Shan Li;Mohammed Alali;Andrew Sloane

  • Immunological abnormalities in the chronic fatigue syndrome.

    Andrew R. Lloyd;Denis Wakefield;Clement R. Boughton;John M. Dwyer

  • Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans.

    U. Vollmer-Conna;C. Fazou;B. Cameron;H. Li

  • Chemokines and serpentines: the molecular biology of chemokine receptors.

    David J. Kelvin;Dennis F. Michiel;James A. Johnston;Andrew R. Lloyd

Frequent Co-Authors

Gregory J. Dore
Gregory J. Dore University of New South Wales
Denis Wakefield
Denis Wakefield University of New South Wales
Jason Grebely
Jason Grebely University of New South Wales
Margaret Hellard
Margaret Hellard Burnet Institute
Ian B. Hickie
Ian B. Hickie University of Sydney
Gail V. Matthews
Gail V. Matthews University of New South Wales
William D. Rawlinson
William D. Rawlinson University of New South Wales
Lisa Maher
Lisa Maher University of New South Wales
John M. Kaldor
John M. Kaldor University of New South Wales
Maria Prins
Maria Prins University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare fields, especially nursing. For those looking to advance their nursing credentials while focusing on immunological health, bridge programs offer a flexible, online option. For example, an fnp to acnp bridge program online allows Family Nurse Practitioners to transition to Acute Care Nurse Practitioners, opening doors to more specialized patient care.

Accelerated programs can speed up your entry into advanced nursing roles. Many students benefit from an accelerated fnp pathway, which condenses essential coursework and clinical experience into a shorter timeframe without sacrificing quality.

For individuals without a nursing background interested in immunology-related healthcare roles, online absn programs for non nurses provide an accessible entry point. These programs are designed to build foundational nursing skills while accommodating the schedules of working professionals.

Moreover, admission to nursing programs can vary widely. Those seeking less competitive entry options might explore absn programs with high acceptance rates, which offer a strategic pathway into nursing careers connected to immunology research and patient care.

Best Scientists Citing Andrew R. Lloyd

Trending Scientists